Location History:
- Thornton, CO (US) (2020)
- New York, NY (US) (2019 - 2023)
Company Filing History:
Years Active: 2019-2025
Title: Christopher Brooks: Innovator in Cancer Vaccine Development
Introduction
Christopher Brooks is a notable inventor based in New York, NY (US). He has made significant contributions to the field of cancer research, particularly in the development of targeted cancer vaccines. With a total of 4 patents to his name, Brooks is recognized for his innovative approaches to treating cancer.
Latest Patents
Among his latest patents, Brooks has developed cancer stem cell targeted cancer vaccines. These vaccines are designed to treat and vaccinate against cancer by utilizing specific regimens that include peptides, compositions, immunomodulatory agents, and emulsifiers. The patents also detail the patient populations for whom these regimens are intended, along with the dosages, schedules, and routes of administration.
Career Highlights
Throughout his career, Christopher Brooks has worked with several prominent companies in the biotechnology sector. Notably, he has been associated with Stemline Therapeutics, Inc. and C&D Zodiac, Inc. His work in these organizations has furthered the development of innovative cancer treatments.
Collaborations
Brooks has collaborated with various professionals in the field, including Ivan Bergstein and Thomas P. Cirrito. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Christopher Brooks stands out as an influential inventor in the realm of cancer vaccine development. His work continues to pave the way for innovative treatments that could significantly impact cancer care.